[The proteinase inhibitor trasylol as therapeutic principle in the tourniquet syndrome].
D000818:Animals; D007611:Aprotinin / Q000627:therapeutic use*; D001775:Blood Circulation; D001808:Blood Vessels / Q000187:drug effects; D004285:Dogs; D004487:Edema / Q000188:drug therapy* / Q000517:prevention & control; D005121:Extremities / Q000098:blood supply*; D007511:Ischemia; D051381:Rats; D013997:Time Factors; D014111:Tourniquets / Q000009:adverse effects*
D007611:Aprotinin
Der Proteinaseimhibitor Trasylol als therapeutisches Prinzip beim Tourniquet-Syndrom.